GEHEP 010 study: Prevalence and distribution of hepatitis B virus genotypes in Spain (2000-2016).


Journal

The Journal of infection
ISSN: 1532-2742
Titre abrégé: J Infect
Pays: England
ID NLM: 7908424

Informations de publication

Date de publication:
10 2020
Historique:
received: 31 12 2019
revised: 29 06 2020
accepted: 17 07 2020
pubmed: 28 7 2020
medline: 19 3 2021
entrez: 26 7 2020
Statut: ppublish

Résumé

To study the prevalence and distribution of HBV genotypes in Spain for the period 2000-2016. Retrospective study recruiting 2559 patients from 17 hospitals. Distribution of HBV genotypes, as well as sex, age, geographical origin, mode of transmission, HDV-, HIV- and/or HCV-coinfection, and treatment were recorded. 1924 chronically HBV native Spanish patients have been recruited. Median age was 54 years (IQR: 41-62), 69.6% male, 6.3% HIV-coinfected, 3.1% were HCV-coinfected, 1.7% HDV-co/superinfected. Genotype distribution was: 55.9% D, 33.5% A, 5.6% F, 0.8% G, and 1.9% other genotypes (E, B, H and C). HBV genotype A was closely associated with male sex, sexual transmission, and HIV-coinfection. In contrast, HBV genotype D was associated with female sex and vertical transmission. Different patterns of genotype distribution and diversity were found between different geographical regions. In addition, HBV epidemiological patterns are evolving in Spain, mainly because of immigration. Finally, similar overall rates of treatment success across all HBV genotypes were found. We present here the most recent data on molecular epidemiology of HBV in Spain (GEHEP010 Study). This study confirms that the HBV genotype distribution in Spain varies based on age, sex, origin, HIV-coinfection, geographical regions and epidemiological groups.

Identifiants

pubmed: 32711039
pii: S0163-4453(20)30496-5
doi: 10.1016/j.jinf.2020.07.019
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

600-606

Informations de copyright

Copyright © 2020. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of Competing Interest No Competing financial and non-financial interests are disclosed by any author

Auteurs

Antonio Aguilera (A)

Complexo Hospitalario Universitario de Santiago, Santiago de Compostela, Instituto de Investigación Sanitaria de Santiago IDIS, Spain.

Rocío Trastoy (R)

Hospital Universitario Vall d'Hebrón, Barcelona, Spain.

Francisco Rodríguez-Frias (F)

Hospital Universitario Vall d'Hebrón, Barcelona, Spain.

Juan Luis Muñoz-Bellido (JL)

Complejo Asistencial Universitario de Salamanca, Salamanca, Spain.

Santiago Melón (S)

Hospital Universitario Central de Asturias, Oviedo, Spain.

Avelina Suárez (A)

Hospital Clínico Universitario San Carlos, Madrid, Spain.

Antonio Orduña (A)

Hospital Clínico Universitario de Valladolid, Valladolid, Spain.

Isabel Viciana (I)

Hospital Universitario Virgen de la Victoria, Málaga, Spain.

Samuel Bernal (S)

Hospital Universitario Virgen de Valme, Sevilla, Spain.

Silvia García-Bujalance (S)

Hospital Universitario La Paz, Madrid, Spain.

Natalia Montiel (N)

Hospital Costa del Sol, Marbella, Spain.

José Manuel Molina (JM)

Hospital Universitario La Fe, Valencia, Spain.

Miren Basaras (M)

Universidad del País Vasco, Bilbao, Spain.

Felipe Fernández-Cuenca (F)

Hospital Universitario Virgen Macarena, Sevilla, Spain.

Isabel García-Arata (I)

Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.

Gabriel Reina (G)

Clínica Universitaria de Navarra, Pamplona, Spain.

María Dolores Ocete (MD)

Hospital Universitario General de Valencia, Valencia, Spain.

Ana Fuentes (A)

Hospital Universitario San Cecilio, Instituto de Investigación Biosanitaria Ibs, Av. de la Innovación S/N, 18016 Granada, Spain.

Daniel Navarro-de la Cruz (D)

Hospital Universitario Vall d'Hebrón, Barcelona, Spain.

Leonardo Nieto (L)

Hospital Universitario Vall d'Hebrón, Barcelona, Spain.

Ana Blazquez de Castro (A)

Complejo Asistencial Universitario de Salamanca, Salamanca, Spain.

María Buti (M)

Hospital Universitario Vall d'Hebrón, Barcelona, Spain.

Marta Álvarez (M)

Hospital Universitario San Cecilio, Instituto de Investigación Biosanitaria Ibs, Av. de la Innovación S/N, 18016 Granada, Spain.

Federico García (F)

Hospital Universitario San Cecilio, Instituto de Investigación Biosanitaria Ibs, Av. de la Innovación S/N, 18016 Granada, Spain. Electronic address: fegarcia@ugr.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH